BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7505714)

  • 1. Mechanisms of action and therapeutic potential of adenosine and its analogues in the treatment of cardiac arrhythmias.
    Pelleg A
    Coron Artery Dis; 1993 Jan; 4(1):109-15. PubMed ID: 7505714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous adenosine does not activate ATP-sensitive potassium channels in the hypoxic guinea pig ventricle in vivo.
    Xu J; Wang L; Hurt CM; Pelleg A
    Circulation; 1994 Mar; 89(3):1209-16. PubMed ID: 8124809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Janus face of adenosine: antiarrhythmic and proarrhythmic actions.
    Szentmiklosi AJ; Galajda Z; Cseppento Á; Gesztelyi R; Susán Z; Hegyi B; Nánási PP
    Curr Pharm Des; 2015; 21(8):965-76. PubMed ID: 25354187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].
    Böhm M
    Klin Wochenschr; 1987 Jun; 65(11):487-99. PubMed ID: 2441109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.
    Malcolm AD; Garratt CJ; Camm AJ
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):139-47. PubMed ID: 8485069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac ion channels: relevance to management of arrhythmias.
    Roden DM; George AL
    Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans.
    Lerman BB; Ellenbogen KA; Kadish A; Platia E; Stein KM; Markowitz SM; Mittal S; Slotwiner DJ; Scheiner M; Iwai S; Belardinelli L; Jerling M; Shreeniwas R; Wolff AA
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):237-45. PubMed ID: 11584330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node.
    Berne RM; DiMarco JP; Belardinelli L
    Circulation; 1984 Jun; 69(6):1195-7. PubMed ID: 6713621
    [No Abstract]   [Full Text] [Related]  

  • 10. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart.
    Belardinelli L; Lu J; Dennis D; Martens J; Shryock JC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1371-82. PubMed ID: 7996449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.
    Mustafa SJ; Morrison RR; Teng B; Pelleg A
    Handb Exp Pharmacol; 2009; (193):161-88. PubMed ID: 19639282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanisms of cardiac electrophysiologic actions of adenosine and adenosine 5'-triphosphate.
    Pelleg A; Miyagawa A; Michelson EL; Dreifus LS
    Prog Clin Biol Res; 1988; 275():225-37. PubMed ID: 3051010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine as a therapeutic agent.
    Mosqueda-Garcia R
    Clin Invest Med; 1992 Oct; 15(5):445-55. PubMed ID: 1458718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of calcium antagonists for cardiac arrhythmias.
    Singh BN; Nademanee K
    Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine as an antiarrhythmic agent.
    Wilbur SL; Marchlinski FE
    Am J Cardiol; 1997 Jun; 79(12A):30-7. PubMed ID: 9223361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of the negative chronotropic and dromotropic actions of adenosine 5'-triphosphate in the heart: an update.
    Pelleg A; Belhassen B
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):106-9. PubMed ID: 20386456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
    Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
    Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation.
    Stark U; Brodmann M; Lueger A; Stark G
    J Crit Care; 2001 Mar; 16(1):8-16. PubMed ID: 11230719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.
    Hellestrand KJ; Nathan AW; Bexton RS; Camm AJ
    Am J Cardiol; 1984 Feb; 53(5):30B-38B. PubMed ID: 6695817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.